- You can view the full Gilead Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
Gilead, Pfizer, Abbvie stand to gain from Lilly and Incyte Rheumatoid Arthritis Setback.
Investors have turned away from biotech at a time when the sector is normally humming with presentations of new clinical data at springtime medical meetings.